These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2269319)

  • 1. Fulminant myasthenia gravis soon after initiation of acebutolol therapy.
    Confavreux C; Charles N; Aimard G
    Eur Neurol; 1990; 30(5):279-81. PubMed ID: 2269319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of essential arterial hypertension with a single daily dose of acebutolol].
    Saettone GP; Cazzani E; Romanò M; Muzio L
    Minerva Med; 1983 Oct; 74(38):2237-40. PubMed ID: 6646473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acebutolol as monotherapy of essential arterial hypertension].
    Mazzaferro S; Giuliano G; Lucchini M; Airoldi G; Finistauri D; Massimetti C; Messa F; Coen G
    Clin Ter; 1984 May; 109(4):315-21. PubMed ID: 6236025
    [No Abstract]   [Full Text] [Related]  

  • 4. Myasthenia gravis and ciprofloxacin.
    Roquer J; Cano A; Seoane JL; Pou Serradell A
    Acta Neurol Scand; 1996 Dec; 94(6):419-20. PubMed ID: 9017031
    [No Abstract]   [Full Text] [Related]  

  • 5. [Controlled comparative trial of acebutolol and bendrofluazide alone or in association for the treatment of hypertension].
    Wheatley D
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3278-81. PubMed ID: 768909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis.
    Marcus SN; Chadwick D; Walker RJ
    Gastroenterology; 1984 Jan; 86(1):166-8. PubMed ID: 6689658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicentre study of a once daily dosage of acebutolol in the treatment of hypertension in general practice.
    Baker PG; Goulton J
    J Int Med Res; 1979; 7(3):201-14. PubMed ID: 456733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised two way crossover comparison of the effects of six weeks propranolol and acebutolol therapy on plasma lipid profiles in patients with hypertension or ischaemic heart disease.
    Tyagi S; Bhargava M; Bhattacharya J; Khalilullah M
    Indian Heart J; 1990; 42(2):117-9. PubMed ID: 2081608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Myasthenia syndrome during chloroquine treatment (author's transl)].
    Schumm F; Wiethölter H; Fateh-Moghadam A
    Dtsch Med Wochenschr; 1981 Dec; 106(51-52):1745-7. PubMed ID: 7327092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acebutolol-induced subacute cutaneous lupus erythematosus.
    Fenniche S; Dhaoui A; Ammar FB; Benmously R; Marrak H; Mokhtar I
    Skin Pharmacol Physiol; 2005; 18(5):230-3. PubMed ID: 16015021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Exacerbation of pseudoparalytic myasthenia gravis following azithromycin (Zithromax)].
    Cadisch R; Streit E; Hartmann K
    Schweiz Med Wochenschr; 1996 Feb; 126(8):308-10. PubMed ID: 8701248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of essential hypertension with beta-blocker plus diuretic: a study of 1402 patients treated by general practitioners with acebutolol 200 mg combined with hydrochlorothiazide 12.5 mg ('Secadrex') once daily for 3 months.
    McGowan GK; Baker PG
    J Int Med Res; 1984; 12(2):87-91. PubMed ID: 6373443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of hypertension in the elderly using a beta-blocker: acebutolol (author's transl)].
    Forette F; Henry JF; Hervy MP; Forette B; Berthaux P
    Nouv Presse Med; 1979 Sep; 8(36):2881-4. PubMed ID: 493093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular, systemic and antinuclear antibody changes with acebutolol.
    Hosie J; Ghafoor SY
    J R Coll Gen Pract; 1983 Dec; 33(257):779-82. PubMed ID: 6606705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible revelation of latent myasthenia gravis by labetalol chlorhydrate.
    Leys D; Pasquier F; Vermersch P; Gosset D; Michiels H; Kassiotis P; Petit H
    Acta Clin Belg; 1987; 42(6):475-6. PubMed ID: 3434123
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycophenolate mofetil in the therapy of severe myasthenia gravis.
    Schneider C; Gold R; Reiners K; Toyka KV
    Eur Neurol; 2001; 46(2):79-82. PubMed ID: 11528156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of rapidity of hypotensive effects of acebutolol on non hospitalized patients (author's transl)].
    Meisel C; Destreguil D; Godeau P
    Sem Hop; 1978 Oct 8-15; 54(29-32):925-8. PubMed ID: 216082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new beta-adrenergic blocking drug in hypertension. A report from the General Practitioner Research Group.
    Practitioner; 1976 Feb; 216(1292):218-21. PubMed ID: 772659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penicillamine-induced myasthenia gravis in a patient with rheumatoid arthritis. A case report.
    Naidoo PD
    S Afr Med J; 1981 Sep; 60(12):478. PubMed ID: 7280897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.